Canada Post Corp Registered Pension Plan Has $2.21 Million Position in Kenvue Inc. $KVUE

Canada Post Corp Registered Pension Plan boosted its position in Kenvue Inc. (NYSE:KVUE) by 338.1% during the third quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 135,056 shares of the company’s stock after buying an additional 104,227 shares during the quarter. Canada Post Corp Registered Pension Plan’s holdings in Kenvue were worth $2,207,000 as of its most recent filing with the SEC.

Several other institutional investors have also recently bought and sold shares of the company. Cornerstone Planning Group LLC raised its holdings in shares of Kenvue by 705.2% in the third quarter. Cornerstone Planning Group LLC now owns 1,554 shares of the company’s stock valued at $25,000 after purchasing an additional 1,361 shares during the last quarter. NBT Bank N A NY increased its stake in Kenvue by 180.3% in the 3rd quarter. NBT Bank N A NY now owns 1,564 shares of the company’s stock valued at $25,000 after buying an additional 1,006 shares during the last quarter. Salomon & Ludwin LLC acquired a new stake in Kenvue in the 3rd quarter valued at $25,000. Golden State Wealth Management LLC lifted its position in Kenvue by 150.1% during the 3rd quarter. Golden State Wealth Management LLC now owns 1,983 shares of the company’s stock worth $32,000 after buying an additional 1,190 shares in the last quarter. Finally, Trust Co. of Vermont boosted its stake in shares of Kenvue by 50.9% during the 3rd quarter. Trust Co. of Vermont now owns 2,385 shares of the company’s stock worth $39,000 after buying an additional 804 shares during the last quarter. Institutional investors own 97.64% of the company’s stock.

Analysts Set New Price Targets

A number of research firms recently issued reports on KVUE. Zacks Research raised Kenvue from a “strong sell” rating to a “hold” rating in a research report on Wednesday, November 26th. Evercore set a $18.00 price target on Kenvue in a research report on Tuesday, October 28th. Barclays upped their price objective on Kenvue from $17.00 to $18.00 and gave the stock an “equal weight” rating in a research note on Monday, November 10th. Jefferies Financial Group cut shares of Kenvue from a “buy” rating to a “hold” rating and decreased their target price for the company from $23.00 to $18.00 in a research note on Friday, January 30th. Finally, Weiss Ratings reiterated a “hold (c-)” rating on shares of Kenvue in a research note on Friday, January 9th. Four research analysts have rated the stock with a Buy rating and twelve have assigned a Hold rating to the stock. According to data from MarketBeat.com, the stock currently has a consensus rating of “Hold” and an average price target of $19.46.

Kenvue Trading Up 0.3%

Shares of Kenvue stock opened at $18.12 on Friday. The company has a debt-to-equity ratio of 0.66, a current ratio of 0.98 and a quick ratio of 0.69. The business has a fifty day simple moving average of $17.24 and a two-hundred day simple moving average of $17.87. Kenvue Inc. has a 1 year low of $14.02 and a 1 year high of $25.17. The company has a market capitalization of $34.72 billion, a price-to-earnings ratio of 24.16 and a beta of 0.59.

Kenvue Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Wednesday, February 25th. Investors of record on Wednesday, February 11th will be paid a $0.2075 dividend. The ex-dividend date is Wednesday, February 11th. This represents a $0.83 dividend on an annualized basis and a yield of 4.6%. Kenvue’s dividend payout ratio is 110.67%.

Insiders Place Their Bets

In related news, Director Jeffrey C. Smith acquired 3,200,000 shares of the business’s stock in a transaction on Friday, December 12th. The stock was purchased at an average cost of $17.37 per share, for a total transaction of $55,584,000.00. Following the completion of the transaction, the director directly owned 27,307,632 shares of the company’s stock, valued at approximately $474,333,567.84. The trade was a 13.27% increase in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. 1.68% of the stock is currently owned by corporate insiders.

Kenvue Company Profile

Kenvue is a consumer health company that was established as a standalone, publicly traded business after separating from Johnson & Johnson. Listed on the New York Stock Exchange under the symbol KVUE, Kenvue focuses on the development, manufacture, marketing and distribution of consumer health and personal care products across a range of categories including skin and beauty care, baby care, oral care, wound care and over‑the‑counter medicines.

The company owns and markets a portfolio of widely recognized consumer brands, including names familiar to global shoppers across retail and pharmacy channels.